Rotella Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-16,300	Closed	-$93K	–	628
2015 Q3	$93K	Buy	16,300 +4,242	+35%	+$24.2K	0.03%	437
2015 Q2	$90K	Buy	+12,058	New	+$90K	0.07%	293
2015 Q1	–	Sell	-36,473	Closed	-$276K	–	640
2014 Q4	$276K	Buy	+36,473	New	+$276K	0.24%	84